Sientra company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

sientra.com

Stage

Loan | IPO

Total Raised

$157.5M

Market Cap

0.05B

Stock Price

0.90

Revenue

$0000 

About Sientra

Sientra is a medical aesthetics company committed to making a difference in patients' lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products.

Sientra Headquarter Location

420 South Fairview Ave

Goleta, California, 93117,

United States

805-562-3500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sientra

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sientra is included in 3 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

1,470 items

Startups focused on providing products and services catering to women's health and wellbeing.

M

Medical Devices

11,681 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

Sientra Patents

Sientra has filed 5 patents.

The 3 most popular patent topics include:

  • Medical equipment
  • Implants (medicine)
  • Prosthetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/29/2020

2/22/2022

Implants (medicine), Wireless networking, Maidu villages, Medical equipment, Prosthetics

Grant

Application Date

4/29/2020

Grant Date

2/22/2022

Title

Related Topics

Implants (medicine), Wireless networking, Maidu villages, Medical equipment, Prosthetics

Status

Grant

Latest Sientra News

Sientra To Present At The William Blair 42nd Annual Growth Stock Conference

May 23, 2022

Santa Barbara, California, UNITED STATES SANTA BARBARA, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the William Blair 42nd Annual Growth Stock Conference, which takes place June 6-9, 2022. As part of the conference, the company’s management team will participate in a live Presentation on Tuesday, June 7, 2022 at 4:00pm CDT / 2:00pm PDT. An on-demand webcast of the presentation will be accessible under “News & Events” in the Investors section of the company’s website at www.sientra.com. A replay of the webcast will be available on the Sientra website for 90 days following the presentation. William Blair hosted events are intended for prospective and existing William Blair clients only. To request a one-on-one meeting with management or to participate at the live event, please contact your William Blair representative with interest. About Sientra Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company exclusively focused on plastic surgery. The Company mission is to offer proprietary innovations and unparalleled partnerships that radically advance how plastic surgeons think, work and care for their patients. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s product portfolio includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, the AuraGen fat grafting system, and BIOCORNEUM®, the #1 performing, preferred and recommended scar gel of plastic surgeons (*). Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at  www.sientra.com . (*) Data on file

Sientra Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sientra Rank

  • Where is Sientra's headquarters?

    Sientra's headquarters is located at 420 South Fairview Ave, Goleta.

  • What is Sientra's latest funding round?

    Sientra's latest funding round is Loan.

  • How much did Sientra raise?

    Sientra raised a total of $157.5M.

  • Who are the investors of Sientra?

    Investors of Sientra include Paycheck Protection Program, OrbiMed Advisors, Clarus, Abingworth, TIAA and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.